TrialPloS one2012
Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.
Sonia Philipose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialPloS one2012
Sonia Philipose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.